S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.75 (+2.84%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
PRI   125.75 (-0.04%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
S&P 500   3,004.52 (+0.28%)
DOW   26,833.95 (+0.17%)
QQQ   192.22 (+0.19%)
AAPL   243.18 (+1.34%)
FB   186.19 (+2.11%)
MSFT   137.24 (+0.64%)
GOOGL   1,257.63 (+1.32%)
AMZN   1,762.17 (-0.20%)
CGC   21.75 (+2.84%)
NVDA   195.09 (-0.27%)
MU   44.66 (+0.00%)
BABA   169.92 (+0.02%)
GE   9.14 (+0.88%)
TSLA   254.68 (-0.35%)
AMD   31.36 (-0.48%)
T   37.74 (-1.13%)
F   9.21 (+1.54%)
ACB   3.67 (+2.51%)
PRI   125.75 (-0.04%)
NFLX   271.27 (+1.72%)
BAC   31.42 (+0.71%)
GILD   66.58 (+1.09%)
DIS   131.13 (-0.96%)
Log in

Clovis Oncology News Headlines (NASDAQ:CLVS)

$3.20
-0.24 (-6.98 %)
(As of 10/23/2019 04:00 PM ET)
Today's Range
$3.20
Now: $3.20
$3.48
50-Day Range
$3.15
MA: $4.27
$5.80
52-Week Range
$3.01
Now: $3.20
$32.05
Volume2.19 million shs
Average Volume2.45 million shs
Market Capitalization$174.90 million
P/E RatioN/A
Dividend YieldN/A
Beta1.86

Headlines

Clovis Oncology (NASDAQ CLVS) News Headlines

Source:
DateHeadline
Clovis Oncology: Debating On Doubling Down Or DitchingClovis Oncology: Debating On Doubling Down Or Ditching
seekingalpha.com - October 23 at 1:25 PM
Clovis Oncology to Announce Third Quarter 2019 Financial Results and Host Webcast Conference Call on November 7Clovis Oncology to Announce Third Quarter 2019 Financial Results and Host Webcast Conference Call on November 7
finance.yahoo.com - October 22 at 8:51 AM
 Analysts Anticipate Clovis Oncology (NASDAQ:CLVS) to Announce -$1.92 Earnings Per Share Analysts Anticipate Clovis Oncology (NASDAQ:CLVS) to Announce -$1.92 Earnings Per Share
www.americanbankingnews.com - October 22 at 5:12 AM
Clovis Oncology (NASDAQ:CLVS) Short Interest Down 6.6% in SeptemberClovis Oncology (NASDAQ:CLVS) Short Interest Down 6.6% in September
www.americanbankingnews.com - October 16 at 1:20 PM
Clovis Oncology Announces Rubraca® (rucaparib) Now Available for Women with Relapsed Ovarian Cancer in England Through the Cancer Drugs FundClovis Oncology Announces Rubraca® (rucaparib) Now Available for Women with Relapsed Ovarian Cancer in England Through the Cancer Drugs Fund
www.benzinga.com - October 11 at 12:50 PM
Clovis Oncology Announces Rubraca®▼ (rucaparib) Now Available for Women with Relapsed Ovarian Cancer in England Through the Cancer Drugs FundClovis Oncology Announces Rubraca®▼ (rucaparib) Now Available for Women with Relapsed Ovarian Cancer in England Through the Cancer Drugs Fund
finance.yahoo.com - October 11 at 12:50 PM
Clovis (CLVS) Shares Drop on Goldman Sachs Bearish OutlookClovis (CLVS) Shares Drop on Goldman Sachs' Bearish Outlook
finance.yahoo.com - October 10 at 8:25 AM
Clovis Oncology (NASDAQ:CLVS) Given Consensus Recommendation of "Hold" by AnalystsClovis Oncology (NASDAQ:CLVS) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - October 10 at 8:12 AM
Clovis Oncologys (CLVS) "Sell" Rating Reaffirmed at Goldman Sachs GroupClovis Oncology's (CLVS) "Sell" Rating Reaffirmed at Goldman Sachs Group
www.americanbankingnews.com - October 8 at 8:15 AM
J&J Gets Breakthrough Therapy Tag for Prostate Cancer DrugJ&J Gets Breakthrough Therapy Tag for Prostate Cancer Drug
finance.yahoo.com - October 4 at 4:28 PM
HC Wainwright Reiterates $36.00 Price Target for Clovis Oncology (NASDAQ:CLVS)HC Wainwright Reiterates $36.00 Price Target for Clovis Oncology (NASDAQ:CLVS)
www.americanbankingnews.com - October 3 at 1:25 AM
Clovis Oncology (NASDAQ:CLVS) Rating Reiterated by JPMorgan Chase & Co.Clovis Oncology (NASDAQ:CLVS) Rating Reiterated by JPMorgan Chase & Co.
www.americanbankingnews.com - October 2 at 7:49 PM
Is Clovis Oncology, Inc.'s (NASDAQ:CLVS) CEO Pay Fair?Is Clovis Oncology, Inc.'s (NASDAQ:CLVS) CEO Pay Fair?
finance.yahoo.com - October 2 at 5:05 PM
$36.31 Million in Sales Expected for Clovis Oncology (NASDAQ:CLVS) This Quarter$36.31 Million in Sales Expected for Clovis Oncology (NASDAQ:CLVS) This Quarter
www.americanbankingnews.com - October 1 at 4:22 AM
Bank of America Analysts Give Clovis Oncology (NASDAQ:CLVS) a $7.00 Price TargetBank of America Analysts Give Clovis Oncology (NASDAQ:CLVS) a $7.00 Price Target
www.americanbankingnews.com - September 30 at 8:21 PM
Clovis Oncology (CLVS) Presents At ESMO Congress 2019 - SlideshowClovis Oncology (CLVS) Presents At ESMO Congress 2019 - Slideshow
seekingalpha.com - September 30 at 5:02 PM
-$1.72 EPS Expected for Clovis Oncology (NASDAQ:CLVS) This Quarter-$1.72 EPS Expected for Clovis Oncology (NASDAQ:CLVS) This Quarter
www.americanbankingnews.com - September 29 at 5:37 PM
CLVS Clovis Oncology, Inc. Common StockCLVS Clovis Oncology, Inc. Common Stock
www.nasdaq.com - September 29 at 4:09 PM
Clovis Oncology Highlights Rubraca® (rucaparib) Updated Data from the Ongoing TRITON2 Clinical Trial in Patients with mCRPC and Exploratory and Integrated Analyses in Recurrent Ovarian Cancer at the ESMO Congress 2019Clovis Oncology Highlights Rubraca® (rucaparib) Updated Data from the Ongoing TRITON2 Clinical Trial in Patients with mCRPC and Exploratory and Integrated Analyses in Recurrent Ovarian Cancer at the ESMO Congress 2019
finance.yahoo.com - September 29 at 6:07 AM
14 Healthcare Stocks Moving In Tuesdays Pre-Market Session14 Healthcare Stocks Moving In Tuesday's Pre-Market Session
www.msn.com - September 24 at 9:55 PM
Clovis Oncology Stock Is Falling After an Analyst Said a Licensing Deal Was Ill TimedClovis Oncology Stock Is Falling After an Analyst Said a Licensing Deal Was Ill Timed
www.barrons.com - September 24 at 4:43 PM
Clovis Oncology Call Volume Spikes After DowngradeClovis Oncology Call Volume Spikes After Downgrade
finance.yahoo.com - September 24 at 4:43 PM
Clovis in-licenses cancer program from 3B PharmaceuticalsClovis in-licenses cancer program from 3B Pharmaceuticals
seekingalpha.com - September 23 at 4:29 PM
Clovis Oncology Acquires Rights to FAP-Targeted Radiopharmaceutical Program from 3B PharmaceuticalsClovis Oncology Acquires Rights to FAP-Targeted Radiopharmaceutical Program from 3B Pharmaceuticals
www.businesswire.com - September 23 at 4:14 AM
Clovis Oncology to Highlight Expanded Data from Rubraca® (rucaparib) TRITON and ARIEL Clinical Programs in Prostate and Ovarian Cancers at the ESMO Congress 2019Clovis Oncology to Highlight Expanded Data from Rubraca® (rucaparib) TRITON and ARIEL Clinical Programs in Prostate and Ovarian Cancers at the ESMO Congress 2019
finance.yahoo.com - September 12 at 4:41 PM
Near an All-Time Low, Is Clovis Oncology a Buy?Near an All-Time Low, Is Clovis Oncology a Buy?
www.fool.com - September 4 at 6:36 AM
Why Is Clovis (CLVS) Down 36.8% Since Last Earnings Report?Why Is Clovis (CLVS) Down 36.8% Since Last Earnings Report?
finance.yahoo.com - August 31 at 6:23 PM
Clovis Oncology to Present at 2019 Wells Fargo Healthcare ConferenceClovis Oncology to Present at 2019 Wells Fargo Healthcare Conference
www.businesswire.com - August 28 at 8:35 AM
Clovis secures additional $13M capital raiseClovis secures additional $13M capital raise
seekingalpha.com - August 23 at 9:14 AM
Thursday 8/22 Insider Buying Report: MMP, CLVSThursday 8/22 Insider Buying Report: MMP, CLVS
www.nasdaq.com - August 22 at 11:25 PM
Clovis Oncology: I Decided To Catch The Falling KnifeClovis Oncology: I Decided To Catch The Falling Knife
seekingalpha.com - August 22 at 11:25 PM
Clovis Oncology Announces Exercise by Initial Purchasers of Their Option to Purchase an Additional $13.0 Million Aggregate Principal Amount of the Company’s 4.50% Convertible Senior Notes Due 2024Clovis Oncology Announces Exercise by Initial Purchasers of Their Option to Purchase an Additional $13.0 Million Aggregate Principal Amount of the Company’s 4.50% Convertible Senior Notes Due 2024
www.businesswire.com - August 22 at 7:10 PM
Clovis chief opens wallet to buy stockClovis chief opens wallet to buy stock
seekingalpha.com - August 19 at 8:12 PM
Who Has Been Buying Clovis Oncology, Inc. (NASDAQ:CLVS) Shares?Who Has Been Buying Clovis Oncology, Inc. (NASDAQ:CLVS) Shares?
finance.yahoo.com - August 18 at 6:35 PM
Clovis Oncology up 10% as Citadel buys inClovis Oncology up 10% as Citadel buys in
seekingalpha.com - August 17 at 8:18 AM
Clovis off 4% premarket on BofA downgradeClovis off 4% premarket on BofA downgrade
seekingalpha.com - August 13 at 11:58 PM
Clovis Oncology Announces Pricing of $250 Million of Convertible Senior NotesClovis Oncology Announces Pricing of $250 Million of Convertible Senior Notes
www.businesswire.com - August 8 at 6:57 PM
Clovis down 5% on positive data for PARP competitor LynparzaClovis down 5% on positive data for PARP competitor Lynparza
seekingalpha.com - August 7 at 11:29 PM
Clovis launches $225M convertible debt offering; shares down 11% after hoursClovis launches $225M convertible debt offering; shares down 11% after hours
seekingalpha.com - August 7 at 11:29 PM
Clovis Oncology to Offer $225 Million of Convertible Senior NotesClovis Oncology to Offer $225 Million of Convertible Senior Notes
finance.yahoo.com - August 7 at 11:29 PM
Edited Transcript of CLVS earnings conference call or presentation 1-Aug-19 12:30pm GMTEdited Transcript of CLVS earnings conference call or presentation 1-Aug-19 12:30pm GMT
finance.yahoo.com - August 5 at 8:51 AM
Clovis (CLVS) Q2 Earnings & Sales Lag Estimates, Shares DownClovis (CLVS) Q2 Earnings & Sales Lag Estimates, Shares Down
finance.yahoo.com - August 3 at 7:43 AM
Clovis Oncology (CLVS) Q2 2019 Earnings Call TranscriptClovis Oncology (CLVS) Q2 2019 Earnings Call Transcript
www.fool.com - August 2 at 6:42 AM
Clovis Oncology Q2 Earnings PreviewClovis Oncology Q2 Earnings Preview
seekingalpha.com - August 2 at 12:58 AM
Here's Why Clovis Oncology Stock Fell as Much as 15.6% TodayHere's Why Clovis Oncology Stock Fell as Much as 15.6% Today
finance.yahoo.com - August 2 at 12:58 AM
Vanda Pharmaceuticals leads healthcare gainers; Abiomed and Clovis Oncology among losersVanda Pharmaceuticals leads healthcare gainers; Abiomed and Clovis Oncology among losers
seekingalpha.com - August 1 at 11:18 AM
Clovis Q2 miss pressures shares, down 12% premarketClovis Q2 miss pressures shares, down 12% premarket
seekingalpha.com - August 1 at 8:49 AM
Clovis Oncology EPS misses by $0.57, misses on revenueClovis Oncology EPS misses by $0.57, misses on revenue
seekingalpha.com - August 1 at 8:49 AM
Clovis showing softness ahead of Q2 report, down 2%Clovis showing softness ahead of Q2 report, down 2%
seekingalpha.com - August 1 at 12:03 AM
Will Clovis Oncology (CLVS) Report Negative Earnings Next Week? What You Should KnowWill Clovis Oncology (CLVS) Report Negative Earnings Next Week? What You Should Know
finance.yahoo.com - July 26 at 7:26 AM
This page was last updated on 10/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel